

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.41678954 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 5.14562365 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 5.02572446 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 5.02572446 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.02572446 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.02572446 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.02572446 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 5.02572446 |
| 9 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.79503893 |
| 10 | response to peptidoglycan (GO:0032494) | 4.34190047 |
| 11 | neutrophil activation (GO:0042119) | 3.83932957 |
| 12 | granulocyte activation (GO:0036230) | 3.82420792 |
| 13 | response to muramyl dipeptide (GO:0032495) | 3.77433664 |
| 14 | regulation of vitamin metabolic process (GO:0030656) | 3.74379424 |
| 15 | positive regulation of interferon-alpha production (GO:0032727) | 3.69406519 |
| 16 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.65330577 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 3.57550023 |
| 18 | immunoglobulin mediated immune response (GO:0016064) | 3.57366958 |
| 19 | regulation of interferon-alpha production (GO:0032647) | 3.54763834 |
| 20 | protein localization to endosome (GO:0036010) | 3.40785294 |
| 21 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.37243323 |
| 22 | response to host immune response (GO:0052572) | 3.35773803 |
| 23 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.35773803 |
| 24 | cell adhesion mediated by integrin (GO:0033627) | 3.35669310 |
| 25 | skin morphogenesis (GO:0043589) | 3.35636902 |
| 26 | respiratory burst (GO:0045730) | 3.29817118 |
| 27 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.24575356 |
| 28 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.23758576 |
| 29 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.22861020 |
| 30 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.21819895 |
| 31 | wound healing, spreading of epidermal cells (GO:0035313) | 3.21658018 |
| 32 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.19956832 |
| 33 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.19476314 |
| 34 | regulation of chronic inflammatory response (GO:0002676) | 3.17744855 |
| 35 | response to host defenses (GO:0052200) | 3.14191670 |
| 36 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.14191670 |
| 37 | response to host (GO:0075136) | 3.14191670 |
| 38 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.10575300 |
| 39 | regulation of chemokine biosynthetic process (GO:0045073) | 3.09895752 |
| 40 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.09819428 |
| 41 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.08843208 |
| 42 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.08119397 |
| 43 | membrane raft organization (GO:0031579) | 3.07327600 |
| 44 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.05399022 |
| 45 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.04385120 |
| 46 | natural killer cell mediated immunity (GO:0002228) | 3.04385120 |
| 47 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.02044189 |
| 48 | myeloid cell activation involved in immune response (GO:0002275) | 2.98130409 |
| 49 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.97730533 |
| 50 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.96396460 |
| 51 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.96396460 |
| 52 | hemidesmosome assembly (GO:0031581) | 2.95562594 |
| 53 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.95194316 |
| 54 | negative regulation of interleukin-12 production (GO:0032695) | 2.92753990 |
| 55 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.91674117 |
| 56 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.91550400 |
| 57 | positive regulation of macrophage differentiation (GO:0045651) | 2.91091209 |
| 58 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.90257456 |
| 59 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.89512555 |
| 60 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.89279497 |
| 61 | NIK/NF-kappaB signaling (GO:0038061) | 2.88106029 |
| 62 | myeloid dendritic cell differentiation (GO:0043011) | 2.87747421 |
| 63 | positive regulation of natural killer cell activation (GO:0032816) | 2.87700450 |
| 64 | myeloid dendritic cell activation (GO:0001773) | 2.86318260 |
| 65 | positive regulation of interferon-beta production (GO:0032728) | 2.85098687 |
| 66 | positive regulation of mast cell activation (GO:0033005) | 2.83084629 |
| 67 | hypotonic response (GO:0006971) | 2.82795391 |
| 68 | regulation of mononuclear cell migration (GO:0071675) | 2.81523103 |
| 69 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.80584650 |
| 70 | negative regulation of cell killing (GO:0031342) | 2.80584650 |
| 71 | B cell mediated immunity (GO:0019724) | 2.78161231 |
| 72 | virion attachment to host cell (GO:0019062) | 2.77861293 |
| 73 | adhesion of symbiont to host cell (GO:0044650) | 2.77861293 |
| 74 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.76089033 |
| 75 | positive regulation of mast cell degranulation (GO:0043306) | 2.76089033 |
| 76 | cellular extravasation (GO:0045123) | 2.74146764 |
| 77 | microglial cell activation (GO:0001774) | 2.73509382 |
| 78 | substrate-dependent cell migration (GO:0006929) | 2.71456273 |
| 79 | response to interferon-alpha (GO:0035455) | 2.71046125 |
| 80 | detection of molecule of bacterial origin (GO:0032490) | 2.70417866 |
| 81 | regulation of mast cell degranulation (GO:0043304) | 2.68879929 |
| 82 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.68617632 |
| 83 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.67239417 |
| 84 | regulation of mast cell activation (GO:0033003) | 2.67006017 |
| 85 | macrophage activation (GO:0042116) | 2.66271800 |
| 86 | leukocyte mediated cytotoxicity (GO:0001909) | 2.66213827 |
| 87 | myeloid leukocyte activation (GO:0002274) | 2.63887565 |
| 88 | response to protozoan (GO:0001562) | 2.63684319 |
| 89 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.62223112 |
| 90 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.61910425 |
| 91 | response to type I interferon (GO:0034340) | 2.61888672 |
| 92 | positive regulation of antigen processing and presentation (GO:0002579) | 2.61376782 |
| 93 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.61301904 |
| 94 | cellular response to type I interferon (GO:0071357) | 2.60630334 |
| 95 | type I interferon signaling pathway (GO:0060337) | 2.60630334 |
| 96 | positive regulation of interleukin-12 production (GO:0032735) | 2.59109167 |
| 97 | wound healing, spreading of cells (GO:0044319) | 2.58974812 |
| 98 | positive regulation of heat generation (GO:0031652) | 2.58277806 |
| 99 | positive regulation of astrocyte differentiation (GO:0048711) | 2.57493532 |
| 100 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.56708946 |
| 101 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 2.56582447 |
| 102 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.56410473 |
| 103 | cellular response to interferon-alpha (GO:0035457) | 2.55641587 |
| 104 | dendritic cell differentiation (GO:0097028) | 2.55623346 |
| 105 | superoxide anion generation (GO:0042554) | 2.55117409 |
| 106 | regulation of antigen processing and presentation (GO:0002577) | 2.54967391 |
| 107 | regulation of integrin activation (GO:0033623) | 2.54908280 |
| 108 | hepatocyte apoptotic process (GO:0097284) | 2.54348374 |
| 109 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.53610302 |
| 110 | regulation of monocyte chemotaxis (GO:0090025) | 2.53421307 |
| 111 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.52981695 |
| 112 | negative regulation of monooxygenase activity (GO:0032769) | 2.52898534 |
| 113 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.52756863 |
| 114 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.52378774 |
| 115 | stress fiber assembly (GO:0043149) | 2.52249866 |
| 116 | cytokine secretion (GO:0050663) | 2.51381486 |
| 117 | regulation of podosome assembly (GO:0071801) | 2.51236327 |
| 118 | positive regulation of interleukin-6 production (GO:0032755) | 2.50832814 |
| 119 | neutrophil mediated immunity (GO:0002446) | 2.50687827 |
| 120 | monocyte chemotaxis (GO:0002548) | 2.49865979 |
| 121 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.49795540 |
| 122 | negative regulation of interleukin-17 production (GO:0032700) | 2.49770969 |
| 123 | defense response to protozoan (GO:0042832) | 2.49527234 |
| 124 | regulation of natural killer cell differentiation (GO:0032823) | 2.48934830 |
| 125 | * leukocyte cell-cell adhesion (GO:0007159) | 2.47820652 |
| 126 | mammary gland epithelial cell proliferation (GO:0033598) | 2.47612260 |
| 127 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.47360437 |
| 128 | regulation of macrophage cytokine production (GO:0010935) | 2.47227540 |
| 129 | pinocytosis (GO:0006907) | 2.40152525 |
| 130 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.39747825 |
| 131 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.39640637 |
| 132 | regulation of response to interferon-gamma (GO:0060330) | 2.39115455 |
| 133 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.38830309 |
| 134 | regulation of T cell tolerance induction (GO:0002664) | 2.38744972 |
| 135 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.38256614 |
| 136 | regulation of natural killer cell activation (GO:0032814) | 2.37641406 |
| 137 | endodermal cell differentiation (GO:0035987) | 2.35756405 |
| 138 | germinal center formation (GO:0002467) | 2.35711568 |
| 139 | regulation of interleukin-17 production (GO:0032660) | 2.33659211 |
| 140 | barbed-end actin filament capping (GO:0051016) | 2.32779559 |
| 141 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.32433562 |
| 142 | T-helper 1 type immune response (GO:0042088) | 2.32363012 |
| 143 | decidualization (GO:0046697) | 2.32129580 |
| 144 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.31989934 |
| 145 | positive regulation of macrophage cytokine production (GO:0060907) | 2.30913737 |
| 146 | regulation of interleukin-12 production (GO:0032655) | 2.30318247 |
| 147 | mesodermal cell differentiation (GO:0048333) | 2.30274447 |
| 148 | mature B cell differentiation involved in immune response (GO:0002313) | 2.29180836 |
| 149 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.29129247 |
| 150 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.29129247 |
| 151 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 2.28971436 |
| 152 | adhesion of symbiont to host (GO:0044406) | 2.28629322 |
| 153 | positive regulation of isotype switching (GO:0045830) | 2.27584619 |
| 154 | positive regulation of extracellular matrix organization (GO:1903055) | 2.27474821 |
| 155 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.26232014 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.09890202 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.90022834 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.85039484 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.29353291 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.10768931 |
| 6 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.02762810 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.45504739 |
| 8 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.41409238 |
| 9 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.30650431 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.30520809 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.25875186 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.14579986 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.05055541 |
| 14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.01973797 |
| 15 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.99831270 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.99423460 |
| 17 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.85980180 |
| 18 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.77618645 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.48581641 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.40616569 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.28117132 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.21904221 |
| 23 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.19756315 |
| 24 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.06556452 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.04395956 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.98268576 |
| 27 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.96561716 |
| 28 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.85887747 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.83199374 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.82099444 |
| 31 | * MYB_26560356_Chip-Seq_TH2_Human | 1.81874618 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.79731826 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.75147962 |
| 34 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.71630343 |
| 35 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.71630343 |
| 36 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.69439012 |
| 37 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.67005683 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.62858441 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.62393906 |
| 40 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.60596427 |
| 41 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.60384472 |
| 42 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.53788086 |
| 43 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.53424346 |
| 44 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.52827199 |
| 45 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.51088706 |
| 46 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51035380 |
| 47 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.49935214 |
| 48 | * MYB_26560356_Chip-Seq_TH1_Human | 1.49685792 |
| 49 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.48740892 |
| 50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.44011870 |
| 51 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.43245368 |
| 52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.42805191 |
| 53 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40827954 |
| 54 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.37739945 |
| 55 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.34089413 |
| 56 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32171405 |
| 57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31181798 |
| 58 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.29415371 |
| 59 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.29149849 |
| 60 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28543323 |
| 61 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.26742940 |
| 62 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.25096030 |
| 63 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.24662346 |
| 64 | GATA1_22025678_ChIP-Seq_K562_Human | 1.23513930 |
| 65 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20379495 |
| 66 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.20109430 |
| 67 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17387508 |
| 68 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.15177368 |
| 69 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.14416013 |
| 70 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.14340046 |
| 71 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12273798 |
| 72 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.10800285 |
| 73 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.09915403 |
| 74 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08523011 |
| 75 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.08241673 |
| 76 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.07555892 |
| 77 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.06728781 |
| 78 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.06053106 |
| 79 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05146306 |
| 80 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04988983 |
| 81 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.04776539 |
| 82 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.04722036 |
| 83 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03713789 |
| 84 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.03527371 |
| 85 | MYC_22102868_ChIP-Seq_BL_Human | 1.03151556 |
| 86 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02912661 |
| 87 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.02550094 |
| 88 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00837121 |
| 89 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.99848281 |
| 90 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99796215 |
| 91 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.98712984 |
| 92 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97851945 |
| 93 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.97835773 |
| 94 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.97694539 |
| 95 | ATF3_27146783_Chip-Seq_COLON_Human | 0.97318298 |
| 96 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.96555145 |
| 97 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.95894237 |
| 98 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.95713681 |
| 99 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.95713681 |
| 100 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.95686012 |
| 101 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.94812438 |
| 102 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.91403630 |
| 103 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.91077010 |
| 104 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.90130146 |
| 105 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89272571 |
| 106 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.89135082 |
| 107 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88518925 |
| 108 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.88238989 |
| 109 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87986823 |
| 110 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.87696112 |
| 111 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.87422329 |
| 112 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86992811 |
| 113 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86908021 |
| 114 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86788985 |
| 115 | TP53_16413492_ChIP-PET_HCT116_Human | 0.83554069 |
| 116 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81465366 |
| 117 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.80665462 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.43322587 |
| 2 | * MP0003436_decreased_susceptibility_to | 3.41693929 |
| 3 | MP0003303_peritoneal_inflammation | 3.10039381 |
| 4 | MP0009785_altered_susceptibility_to | 2.92070076 |
| 5 | * MP0002148_abnormal_hypersensitivity_rea | 2.68507005 |
| 6 | * MP0002419_abnormal_innate_immunity | 2.60692790 |
| 7 | * MP0005000_abnormal_immune_tolerance | 2.58988124 |
| 8 | MP0003724_increased_susceptibility_to | 2.39806605 |
| 9 | MP0000685_abnormal_immune_system | 2.37679642 |
| 10 | MP0003950_abnormal_plasma_membrane | 2.36401981 |
| 11 | * MP0005025_abnormal_response_to | 2.29979071 |
| 12 | MP0008438_abnormal_cutaneous_collagen | 2.27097137 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.24235464 |
| 14 | * MP0001790_abnormal_immune_system | 2.17809700 |
| 15 | * MP0005387_immune_system_phenotype | 2.17809700 |
| 16 | * MP0001533_abnormal_skeleton_physiology | 2.10292163 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.03754300 |
| 18 | MP0001800_abnormal_humoral_immune | 2.03238594 |
| 19 | MP0003566_abnormal_cell_adhesion | 2.02070088 |
| 20 | MP0002723_abnormal_immune_serum | 2.01959993 |
| 21 | MP0005671_abnormal_response_to | 1.98925377 |
| 22 | MP0004947_skin_inflammation | 1.93264832 |
| 23 | MP0006082_CNS_inflammation | 1.92611421 |
| 24 | MP0010352_gastrointestinal_tract_polyps | 1.92102791 |
| 25 | MP0001853_heart_inflammation | 1.88653360 |
| 26 | MP0004510_myositis | 1.87544906 |
| 27 | * MP0001819_abnormal_immune_cell | 1.87104207 |
| 28 | MP0002405_respiratory_system_inflammati | 1.85979339 |
| 29 | * MP0002420_abnormal_adaptive_immunity | 1.85814684 |
| 30 | MP0003448_altered_tumor_morphology | 1.81946621 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.80206590 |
| 32 | MP0000858_altered_metastatic_potential | 1.73742575 |
| 33 | MP0002006_tumorigenesis | 1.73199974 |
| 34 | MP0009840_abnormal_foam_cell | 1.73075105 |
| 35 | MP0005275_abnormal_skin_tensile | 1.71515997 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.70544200 |
| 37 | MP0002933_joint_inflammation | 1.68616722 |
| 38 | MP0000343_altered_response_to | 1.68328595 |
| 39 | MP0005058_abnormal_lysosome_morphology | 1.67492300 |
| 40 | MP0009278_abnormal_bone_marrow | 1.66315308 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.66168438 |
| 42 | MP0002166_altered_tumor_susceptibility | 1.64976979 |
| 43 | MP0002877_abnormal_melanocyte_morpholog | 1.63732552 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.59914478 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.59914478 |
| 46 | MP0005023_abnormal_wound_healing | 1.57368203 |
| 47 | MP0002998_abnormal_bone_remodeling | 1.55847727 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.55721994 |
| 49 | MP0000569_abnormal_digit_pigmentation | 1.54631876 |
| 50 | MP0005076_abnormal_cell_differentiation | 1.52263551 |
| 51 | MP0000015_abnormal_ear_pigmentation | 1.44742356 |
| 52 | MP0003279_aneurysm | 1.41387221 |
| 53 | MP0009764_decreased_sensitivity_to | 1.39753476 |
| 54 | MP0003091_abnormal_cell_migration | 1.38803267 |
| 55 | * MP0005390_skeleton_phenotype | 1.38462178 |
| 56 | MP0003453_abnormal_keratinocyte_physiol | 1.38311355 |
| 57 | * MP0000716_abnormal_immune_system | 1.34480007 |
| 58 | MP0002398_abnormal_bone_marrow | 1.33349500 |
| 59 | MP0009333_abnormal_splenocyte_physiolog | 1.33086860 |
| 60 | MP0000465_gastrointestinal_hemorrhage | 1.31214159 |
| 61 | MP0005451_abnormal_body_composition | 1.28233852 |
| 62 | MP0004808_abnormal_hematopoietic_stem | 1.28148425 |
| 63 | MP0008004_abnormal_stomach_pH | 1.28119650 |
| 64 | MP0002396_abnormal_hematopoietic_system | 1.27011252 |
| 65 | MP0000371_diluted_coat_color | 1.26966954 |
| 66 | MP0002060_abnormal_skin_morphology | 1.22772199 |
| 67 | MP0001958_emphysema | 1.22067901 |
| 68 | MP0003828_pulmonary_edema | 1.21683473 |
| 69 | MP0005171_absent_coat_pigmentation | 1.19555733 |
| 70 | MP0004381_abnormal_hair_follicle | 1.18739938 |
| 71 | MP0008469_abnormal_protein_level | 1.16447759 |
| 72 | MP0006054_spinal_hemorrhage | 1.14649196 |
| 73 | MP0005408_hypopigmentation | 1.12696438 |
| 74 | * MP0002429_abnormal_blood_cell | 1.09921827 |
| 75 | MP0005257_abnormal_intraocular_pressure | 1.09757463 |
| 76 | MP0000689_abnormal_spleen_morphology | 1.09481968 |
| 77 | MP0003075_altered_response_to | 1.09393110 |
| 78 | MP0002254_reproductive_system_inflammat | 1.08305788 |
| 79 | MP0000490_abnormal_crypts_of | 1.07993622 |
| 80 | MP0010307_abnormal_tumor_latency | 1.07538384 |
| 81 | MP0003806_abnormal_nucleotide_metabolis | 1.07375498 |
| 82 | MP0003172_abnormal_lysosome_physiology | 1.07292100 |
| 83 | MP0004272_abnormal_basement_membrane | 1.06120279 |
| 84 | MP0005165_increased_susceptibility_to | 1.05443025 |
| 85 | MP0002722_abnormal_immune_system | 1.03795267 |
| 86 | MP0003795_abnormal_bone_structure | 1.02514797 |
| 87 | MP0008260_abnormal_autophagy | 1.01267186 |
| 88 | MP0004883_abnormal_blood_vessel | 0.98715914 |
| 89 | MP0002332_abnormal_exercise_endurance | 0.98399348 |
| 90 | MP0001243_abnormal_dermal_layer | 0.98381094 |
| 91 | MP0001851_eye_inflammation | 0.98119954 |
| 92 | MP0005164_abnormal_response_to | 0.97532454 |
| 93 | MP0000767_abnormal_smooth_muscle | 0.97123982 |
| 94 | MP0004782_abnormal_surfactant_physiolog | 0.94698236 |
| 95 | MP0003763_abnormal_thymus_physiology | 0.93945032 |
| 96 | MP0001216_abnormal_epidermal_layer | 0.93445875 |
| 97 | MP0001542_abnormal_bone_strength | 0.92959944 |
| 98 | MP0001849_ear_inflammation | 0.92666169 |
| 99 | MP0005174_abnormal_tail_pigmentation | 0.92338506 |
| 100 | MP0001873_stomach_inflammation | 0.92280037 |
| 101 | MP0002138_abnormal_hepatobiliary_system | 0.92070197 |
| 102 | MP0003191_abnormal_cellular_cholesterol | 0.89308056 |
| 103 | MP0005166_decreased_susceptibility_to | 0.88355418 |
| 104 | MP0000733_abnormal_muscle_development | 0.86615578 |
| 105 | MP0003656_abnormal_erythrocyte_physiolo | 0.84027788 |
| 106 | MP0001348_abnormal_lacrimal_gland | 0.82060689 |
| 107 | MP0000249_abnormal_blood_vessel | 0.81013808 |
| 108 | MP0002282_abnormal_trachea_morphology | 0.76970626 |
| 109 | MP0002896_abnormal_bone_mineralization | 0.76758083 |
| 110 | MP0005623_abnormal_meninges_morphology | 0.75687444 |
| 111 | MP0001191_abnormal_skin_condition | 0.75301660 |
| 112 | MP0005310_abnormal_salivary_gland | 0.73769084 |
| 113 | MP0003045_fibrosis | 0.72136874 |
| 114 | MP0009763_increased_sensitivity_to | 0.71185152 |
| 115 | MP0005503_abnormal_tendon_morphology | 0.70299368 |
| 116 | MP0000604_amyloidosis | 0.67514930 |
| 117 | MP0003183_abnormal_peptide_metabolism | 0.67508686 |
| 118 | MP0001879_abnormal_lymphatic_vessel | 0.65888792 |
| 119 | MP0002277_abnormal_respiratory_mucosa | 0.65836584 |
| 120 | MP0002113_abnormal_skeleton_development | 0.65077411 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.53886213 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.24536315 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.92417179 |
| 4 | Myositis (HP:0100614) | 3.87860639 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.82027352 |
| 6 | Orchitis (HP:0100796) | 3.62229658 |
| 7 | Abnormality of macrophages (HP:0004311) | 3.59685363 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.51844703 |
| 9 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.48764722 |
| 10 | Osteolytic defects of the hand bones (HP:0009699) | 3.48764722 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 3.46170177 |
| 12 | Follicular hyperkeratosis (HP:0007502) | 3.37385799 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 3.26563262 |
| 14 | Optic neuritis (HP:0100653) | 3.26563262 |
| 15 | Vertebral compression fractures (HP:0002953) | 3.19739114 |
| 16 | Interstitial pulmonary disease (HP:0006530) | 3.02635456 |
| 17 | Premature rupture of membranes (HP:0001788) | 3.02198883 |
| 18 | Gingivitis (HP:0000230) | 3.01632256 |
| 19 | Thick nail (HP:0001805) | 2.98067436 |
| 20 | Recurrent fungal infections (HP:0002841) | 2.96938616 |
| 21 | Recurrent skin infections (HP:0001581) | 2.95434978 |
| 22 | Periodontitis (HP:0000704) | 2.94243565 |
| 23 | Syringomyelia (HP:0003396) | 2.90683451 |
| 24 | Spinal cord lesions (HP:0100561) | 2.90683451 |
| 25 | Absent frontal sinuses (HP:0002688) | 2.86134596 |
| 26 | Peritonitis (HP:0002586) | 2.85419970 |
| 27 | Increased cerebral lipofuscin (HP:0011813) | 2.81006056 |
| 28 | Obstructive lung disease (HP:0006536) | 2.80785349 |
| 29 | Chronic obstructive pulmonary disease (HP:0006510) | 2.80785349 |
| 30 | Cellulitis (HP:0100658) | 2.79870106 |
| 31 | Autoimmune thrombocytopenia (HP:0001973) | 2.77334633 |
| 32 | Stomatitis (HP:0010280) | 2.76561994 |
| 33 | Pustule (HP:0200039) | 2.76461526 |
| 34 | Vascular tortuosity (HP:0004948) | 2.76396466 |
| 35 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.70190059 |
| 36 | Vacuolated lymphocytes (HP:0001922) | 2.70124501 |
| 37 | Myocardial infarction (HP:0001658) | 2.65611269 |
| 38 | Arterial tortuosity (HP:0005116) | 2.63257258 |
| 39 | T lymphocytopenia (HP:0005403) | 2.54276456 |
| 40 | Recurrent viral infections (HP:0004429) | 2.50427466 |
| 41 | Vasculitis (HP:0002633) | 2.50029418 |
| 42 | Protrusio acetabuli (HP:0003179) | 2.47536189 |
| 43 | Abnormality of T cell number (HP:0011839) | 2.45066982 |
| 44 | Cervical subluxation (HP:0003308) | 2.42813101 |
| 45 | Atrophic scars (HP:0001075) | 2.40455043 |
| 46 | Ankle contracture (HP:0006466) | 2.40056376 |
| 47 | Loss of speech (HP:0002371) | 2.37816586 |
| 48 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.37623863 |
| 49 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.37623863 |
| 50 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.37623863 |
| 51 | Alopecia of scalp (HP:0002293) | 2.37605848 |
| 52 | Mucopolysacchariduria (HP:0008155) | 2.35849766 |
| 53 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.35849766 |
| 54 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.35666349 |
| 55 | Pulmonary infiltrates (HP:0002113) | 2.33682208 |
| 56 | Prostate neoplasm (HP:0100787) | 2.27964978 |
| 57 | Arterial thrombosis (HP:0004420) | 2.26654493 |
| 58 | Osteomyelitis (HP:0002754) | 2.26614054 |
| 59 | Axonal loss (HP:0003447) | 2.18849583 |
| 60 | Urticaria (HP:0001025) | 2.18187525 |
| 61 | Hematochezia (HP:0002573) | 2.16997130 |
| 62 | Increased density of long bones (HP:0006392) | 2.16040376 |
| 63 | Albinism (HP:0001022) | 2.14849403 |
| 64 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.12984968 |
| 65 | Abnormality of the frontal sinuses (HP:0002687) | 2.12561324 |
| 66 | Neurofibrillary tangles (HP:0002185) | 2.09028999 |
| 67 | Disinhibition (HP:0000734) | 2.09011499 |
| 68 | Spondylolisthesis (HP:0003302) | 2.07251359 |
| 69 | Short nail (HP:0001799) | 2.06850170 |
| 70 | Autoimmune hemolytic anemia (HP:0001890) | 2.05805095 |
| 71 | Leukocytosis (HP:0001974) | 2.05469307 |
| 72 | Basal ganglia calcification (HP:0002135) | 2.05407661 |
| 73 | Nuclear cataract (HP:0100018) | 2.00244751 |
| 74 | Thrombocytosis (HP:0001894) | 1.99706370 |
| 75 | Meningitis (HP:0001287) | 1.99592395 |
| 76 | Abnormality of the pericardium (HP:0001697) | 1.98345958 |
| 77 | Fragile skin (HP:0001030) | 1.98344280 |
| 78 | Chronic otitis media (HP:0000389) | 1.97844155 |
| 79 | Recurrent cutaneous fungal infections (HP:0011370) | 1.96375633 |
| 80 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.96375633 |
| 81 | Recurrent pneumonia (HP:0006532) | 1.94453324 |
| 82 | Dilatation of the ascending aorta (HP:0005111) | 1.94280666 |
| 83 | Cheilitis (HP:0100825) | 1.93760693 |
| 84 | Keratoconjunctivitis sicca (HP:0001097) | 1.93705509 |
| 85 | Skin ulcer (HP:0200042) | 1.92780483 |
| 86 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.90577249 |
| 87 | Aortic dissection (HP:0002647) | 1.88496661 |
| 88 | Ocular albinism (HP:0001107) | 1.87729146 |
| 89 | Premature loss of primary teeth (HP:0006323) | 1.87319378 |
| 90 | Amyloidosis (HP:0011034) | 1.86783173 |
| 91 | Fatigue (HP:0012378) | 1.86329179 |
| 92 | Epiphyseal dysplasia (HP:0002656) | 1.84876165 |
| 93 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.84798027 |
| 94 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.83733822 |
| 95 | Systemic lupus erythematosus (HP:0002725) | 1.83561968 |
| 96 | Elbow flexion contracture (HP:0002987) | 1.83321782 |
| 97 | Hypergammaglobulinemia (HP:0010702) | 1.83255128 |
| 98 | Wormian bones (HP:0002645) | 1.82374355 |
| 99 | Chronic diarrhea (HP:0002028) | 1.81162477 |
| 100 | Gingival bleeding (HP:0000225) | 1.80532475 |
| 101 | Gangrene (HP:0100758) | 1.79848021 |
| 102 | Milia (HP:0001056) | 1.79788894 |
| 103 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.79603846 |
| 104 | Aortic aneurysm (HP:0004942) | 1.78670792 |
| 105 | Cerebral inclusion bodies (HP:0100314) | 1.78647731 |
| 106 | Aneurysm (HP:0002617) | 1.78150510 |
| 107 | Hemoptysis (HP:0002105) | 1.77053689 |
| 108 | Recurrent lower respiratory tract infections (HP:0002783) | 1.76893488 |
| 109 | Genu recurvatum (HP:0002816) | 1.76506724 |
| 110 | Onycholysis (HP:0001806) | 1.76440613 |
| 111 | Subacute progressive viral hepatitis (HP:0006572) | 1.76326095 |
| 112 | Blue sclerae (HP:0000592) | 1.74357049 |
| 113 | Glomerulopathy (HP:0100820) | 1.74258643 |
| 114 | Spinal rigidity (HP:0003306) | 1.74199141 |
| 115 | Dysostosis multiplex (HP:0000943) | 1.74007261 |
| 116 | Keratoconjunctivitis (HP:0001096) | 1.72566155 |
| 117 | Persistence of primary teeth (HP:0006335) | 1.72452614 |
| 118 | Abnormality of the lumbar spine (HP:0100712) | 1.71781509 |
| 119 | Cupped ribs (HP:0000887) | 1.71711655 |
| 120 | Petechiae (HP:0000967) | 1.71456393 |
| 121 | Arthralgia (HP:0002829) | 1.71064760 |
| 122 | Nail dystrophy (HP:0008404) | 1.70504072 |
| 123 | Natal tooth (HP:0000695) | 1.70327007 |
| 124 | Anhidrosis (HP:0000970) | 1.70297582 |
| 125 | Beaking of vertebral bodies (HP:0004568) | 1.70026008 |
| 126 | Cerebral aneurysm (HP:0004944) | 1.69920956 |
| 127 | Spontaneous hematomas (HP:0007420) | 1.69710306 |
| 128 | Bone pain (HP:0002653) | 1.69589540 |
| 129 | Increased IgE level (HP:0003212) | 1.69558894 |
| 130 | Coxa vara (HP:0002812) | 1.68745944 |
| 131 | Glucose intolerance (HP:0000833) | 1.68278181 |
| 132 | Eosinophilia (HP:0001880) | 1.65379613 |
| 133 | Abnormal platelet volume (HP:0011876) | 1.64899734 |
| 134 | Abnormality of glycolipid metabolism (HP:0010969) | 1.63494279 |
| 135 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.63494279 |
| 136 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.63494279 |
| 137 | Increased IgM level (HP:0003496) | 1.62779879 |
| 138 | Distal lower limb amyotrophy (HP:0008944) | 1.61829493 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 3.71272430 |
| 2 | TBK1 | 2.89951431 |
| 3 | PIM2 | 2.78283697 |
| 4 | RIPK4 | 2.54660994 |
| 5 | GRK7 | 2.53753876 |
| 6 | IRAK4 | 2.42366941 |
| 7 | JAK3 | 2.39454705 |
| 8 | MAP4K1 | 2.33277819 |
| 9 | ERN1 | 2.20486747 |
| 10 | TYK2 | 2.19174133 |
| 11 | IKBKB | 2.15288082 |
| 12 | IRAK3 | 2.08394761 |
| 13 | BLK | 2.07352061 |
| 14 | NME2 | 1.98749740 |
| 15 | PRPF4B | 1.97417702 |
| 16 | IKBKE | 1.88353755 |
| 17 | RPS6KA4 | 1.87484273 |
| 18 | KIT | 1.85562260 |
| 19 | STK10 | 1.85437968 |
| 20 | TRPM7 | 1.85358712 |
| 21 | BMPR2 | 1.76479364 |
| 22 | PDGFRA | 1.75028031 |
| 23 | TXK | 1.73381179 |
| 24 | MAP3K3 | 1.72366715 |
| 25 | NEK9 | 1.62816789 |
| 26 | TTN | 1.61909381 |
| 27 | MYLK | 1.59130354 |
| 28 | JAK1 | 1.57468179 |
| 29 | MST4 | 1.56286137 |
| 30 | CHUK | 1.55793288 |
| 31 | LRRK2 | 1.55746519 |
| 32 | LMTK2 | 1.52580888 |
| 33 | CSK | 1.52022301 |
| 34 | MST1R | 1.49378741 |
| 35 | TEC | 1.39929035 |
| 36 | BMX | 1.38790679 |
| 37 | ZAP70 | 1.36402216 |
| 38 | EPHB1 | 1.35481136 |
| 39 | MAP2K3 | 1.33436647 |
| 40 | PIM1 | 1.33281027 |
| 41 | CDC42BPA | 1.29990549 |
| 42 | EPHA2 | 1.29550798 |
| 43 | TGFBR2 | 1.27417361 |
| 44 | PBK | 1.27214420 |
| 45 | SIK1 | 1.24980568 |
| 46 | TRIB3 | 1.21576491 |
| 47 | HCK | 1.19497253 |
| 48 | BTK | 1.19256163 |
| 49 | TAOK3 | 1.16124193 |
| 50 | EPHA3 | 1.08608671 |
| 51 | ERBB3 | 1.03483030 |
| 52 | TESK1 | 1.02916398 |
| 53 | CDK6 | 1.01928877 |
| 54 | MAP3K13 | 1.00396523 |
| 55 | MOS | 0.98956462 |
| 56 | FGFR3 | 0.94756544 |
| 57 | MATK | 0.94719744 |
| 58 | LCK | 0.94392037 |
| 59 | SYK | 0.94133414 |
| 60 | ITK | 0.93997507 |
| 61 | MAP3K12 | 0.90530737 |
| 62 | STK3 | 0.90523257 |
| 63 | FLT3 | 0.88553353 |
| 64 | EIF2AK3 | 0.88523793 |
| 65 | CSF1R | 0.88402813 |
| 66 | RIPK1 | 0.85855693 |
| 67 | LYN | 0.85123915 |
| 68 | ABL2 | 0.83989542 |
| 69 | DDR2 | 0.82808349 |
| 70 | MAP3K11 | 0.82434374 |
| 71 | PTK6 | 0.82271302 |
| 72 | MARK3 | 0.82127125 |
| 73 | PAK4 | 0.80063546 |
| 74 | TAOK1 | 0.79191622 |
| 75 | LIMK1 | 0.76194597 |
| 76 | PRKD2 | 0.75960409 |
| 77 | MELK | 0.75853741 |
| 78 | FGFR4 | 0.72787980 |
| 79 | PKN2 | 0.71772840 |
| 80 | NUAK1 | 0.71330741 |
| 81 | ERBB4 | 0.68441905 |
| 82 | MAP3K5 | 0.68307686 |
| 83 | JAK2 | 0.68299216 |
| 84 | MAPKAPK2 | 0.68034792 |
| 85 | STK38 | 0.67748360 |
| 86 | ABL1 | 0.67550607 |
| 87 | CLK1 | 0.67295179 |
| 88 | GSK3A | 0.64725175 |
| 89 | MAP2K6 | 0.63946507 |
| 90 | EGFR | 0.63851704 |
| 91 | TSSK6 | 0.63469080 |
| 92 | PRKG2 | 0.60838747 |
| 93 | STK24 | 0.60750863 |
| 94 | STK4 | 0.59083012 |
| 95 | LATS2 | 0.58155045 |
| 96 | PIK3CG | 0.57448357 |
| 97 | EIF2AK2 | 0.56930467 |
| 98 | PRKCD | 0.56807641 |
| 99 | DMPK | 0.55970449 |
| 100 | FER | 0.54178722 |
| 101 | IRAK1 | 0.53760792 |
| 102 | MAP3K8 | 0.52036513 |
| 103 | CDK12 | 0.51807567 |
| 104 | ARAF | 0.50684921 |
| 105 | PTK2B | 0.50447785 |
| 106 | FGR | 0.50162907 |
| 107 | PDGFRB | 0.49857875 |
| 108 | PTK2 | 0.48632814 |
| 109 | ROCK2 | 0.47338176 |
| 110 | TAOK2 | 0.47048523 |
| 111 | KSR1 | 0.45672023 |
| 112 | RPS6KA6 | 0.45484589 |
| 113 | MAPK7 | 0.44817294 |
| 114 | ICK | 0.43610629 |
| 115 | FES | 0.43500723 |
| 116 | MAP3K10 | 0.43468131 |
| 117 | HIPK2 | 0.43197534 |
| 118 | AKT3 | 0.43110725 |
| 119 | TGFBR1 | 0.41897485 |
| 120 | MET | 0.39036119 |
| 121 | SCYL2 | 0.38658099 |
| 122 | PAK2 | 0.37968629 |
| 123 | DYRK1B | 0.36831125 |
| 124 | MAP3K1 | 0.33097049 |
| 125 | YES1 | 0.32057382 |
| 126 | INSR | 0.31612452 |
| 127 | EIF2AK1 | 0.31413224 |
| 128 | RPS6KL1 | 0.30781746 |
| 129 | RPS6KC1 | 0.30781746 |
| 130 | SIK3 | 0.30688262 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.06191042 |
| 2 | Malaria_Homo sapiens_hsa05144 | 2.48810901 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.34670091 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.31960145 |
| 5 | Legionellosis_Homo sapiens_hsa05134 | 2.31253691 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.30899275 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.23191049 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.14910704 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.04119395 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.03310621 |
| 11 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.98783842 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 1.95481333 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 1.92129406 |
| 14 | Measles_Homo sapiens_hsa05162 | 1.91083446 |
| 15 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.79795154 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.75721508 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.75139454 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.70595828 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.67916829 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.65992882 |
| 21 | Salmonella infection_Homo sapiens_hsa05132 | 1.65815004 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.59908081 |
| 23 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.57882554 |
| 24 | Apoptosis_Homo sapiens_hsa04210 | 1.57054401 |
| 25 | Phagosome_Homo sapiens_hsa04145 | 1.56006659 |
| 26 | * Shigellosis_Homo sapiens_hsa05131 | 1.53341447 |
| 27 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.52475860 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.49448391 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.49294518 |
| 30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.48521121 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.46498154 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.45459552 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.44697317 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.39577367 |
| 35 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.39008536 |
| 36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.38651780 |
| 37 | Lysosome_Homo sapiens_hsa04142 | 1.38494246 |
| 38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.35092613 |
| 39 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.35060349 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.34205998 |
| 41 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.33845879 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.31377035 |
| 43 | Amoebiasis_Homo sapiens_hsa05146 | 1.23295268 |
| 44 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.22161938 |
| 45 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.21279904 |
| 46 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.18678132 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.15084115 |
| 48 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.10230014 |
| 49 | Other glycan degradation_Homo sapiens_hsa00511 | 1.05793778 |
| 50 | * ECM-receptor interaction_Homo sapiens_hsa04512 | 1.05723791 |
| 51 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.01932080 |
| 52 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.01834570 |
| 53 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.01089806 |
| 54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.00958606 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.98895858 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.95853689 |
| 57 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.95470945 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.94797855 |
| 59 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.94625719 |
| 60 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.94234420 |
| 61 | Hepatitis C_Homo sapiens_hsa05160 | 0.92969093 |
| 62 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.92812203 |
| 63 | Focal adhesion_Homo sapiens_hsa04510 | 0.91611194 |
| 64 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.79844961 |
| 65 | Prion diseases_Homo sapiens_hsa05020 | 0.79697304 |
| 66 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.79692103 |
| 67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.77692344 |
| 68 | Adherens junction_Homo sapiens_hsa04520 | 0.76935413 |
| 69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76186838 |
| 70 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.74126978 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73500844 |
| 72 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71366245 |
| 73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.70623680 |
| 74 | Bladder cancer_Homo sapiens_hsa05219 | 0.68971783 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64183555 |
| 76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63449932 |
| 77 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.62738321 |
| 78 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.62003067 |
| 79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60289364 |
| 80 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.58416251 |
| 81 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.54404985 |
| 82 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.53410199 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51921739 |
| 84 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.49241168 |
| 85 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48277638 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47825339 |
| 87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.45722128 |
| 88 | Prostate cancer_Homo sapiens_hsa05215 | 0.45578158 |
| 89 | Melanoma_Homo sapiens_hsa05218 | 0.43296662 |
| 90 | Pathways in cancer_Homo sapiens_hsa05200 | 0.42820823 |
| 91 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42703971 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 0.41704741 |
| 93 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41651401 |
| 94 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41213333 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.40232840 |
| 96 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37102686 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36912510 |
| 98 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35758572 |
| 99 | Colorectal cancer_Homo sapiens_hsa05210 | 0.34770403 |
| 100 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.32343628 |
| 101 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.32338493 |
| 102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32238129 |
| 103 | Thyroid cancer_Homo sapiens_hsa05216 | 0.31027097 |
| 104 | Glioma_Homo sapiens_hsa05214 | 0.30976204 |
| 105 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.30154270 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.28235280 |
| 107 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.27562719 |
| 108 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.26720108 |

